Works matching DE "STEM cell transplantation"

Results: 5000
    1

    CALR-mutated myeloproliferative neoplasms.

    Published in:
    Leukemia & Lymphoma, 2025, v. 66, n. 7, p. 1198, doi. 10.1080/10428194.2025.2465551
    By:
    • Bellani, Valentina;
    • Mora, Barbara;
    • Iurlo, Alessandra;
    • Passamonti, Francesco
    Publication type:
    Article
    2
    3
    4
    5
    6

    High NK cell counts at day 90 predict improved survival in event-free patients after T-cell depleted allogeneic stem cell transplantation.

    Published in:
    Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1577924
    By:
    • Pešić, Andrej;
    • Bešević, Nevena;
    • Kröger, Nicolaus;
    • Stanisavljević, Dejana;
    • Kraguljac Kurtović, Nada;
    • Bukumirić, Zoran;
    • Kecman, Natalija;
    • Lemajić, Nikola;
    • Smiljanić, Mihailo;
    • Suvajdžić Vuković, Nada;
    • Bogdanović, Andrija;
    • Vidović, Ana;
    • Bila, Jelena;
    • Mitrović, Mirjana;
    • Leković, Danijela;
    • Virijević, Marijana;
    • Đunić, Irena;
    • Antić, Darko;
    • Todorović Balint, Milena
    Publication type:
    Article
    7
    8
    9

    Cost‐Effectiveness of Preemptive Plerixafor Versus Rescue Plerixafor for Mobilization and Collection of Hematopoietic Stem Cells in Patients With Multiple Myeloma and Lymphoma.

    Published in:
    Journal of Clinical Apheresis, 2025, v. 40, n. 3, p. 1, doi. 10.1002/jca.70026
    By:
    • Passos, Roselene Mesquita Augusto;
    • Marcolino, Miriam Allein Zago;
    • Passos, Júlia Augusto;
    • Calsavara, Vinicius Fernando;
    • de Lourdes Martins Perobelli, Leila;
    • Campolina, Alessandro Gonçalves;
    • de Almeida‐Neto, Cesar
    Publication type:
    Article
    10
    11
    12
    13

    Correction: Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion.

    Published in:
    2025
    By:
    • Koster, Eva A. S.;
    • Bonneville, Edouard F.;
    • von dem Borne, Peter A.;
    • van Balen, Peter;
    • Marijt, Erik W. A.;
    • Tjon, Jennifer M. L.;
    • Snijders, Tjeerd J. F.;
    • van Lammeren, Daniëlle;
    • Veelken, Hendrik;
    • Putter, Hein;
    • Falkenburg, J. H. Frederik;
    • Halkes, Constantijn J. M.;
    • de Wreede, Liesbeth C.
    Publication type:
    Correction Notice
    14

    Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion.

    Published in:
    Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2023.1208814
    By:
    • Koster, Eva A. S.;
    • Bonneville, Edouard F.;
    • von dem Borne, Peter A.;
    • van Balen, Peter;
    • Marijt, Erik W. A.;
    • Tjon, Jennifer M. L.;
    • Snijders, Tjeerd J. F.;
    • van Lammeren, Daniëlle;
    • Veelken, Hendrik;
    • Putter, Hein;
    • Falkenburg, J. H. Frederik;
    • Halkes, Constantijn J. M.;
    • de Wreede, Liesbeth C.
    Publication type:
    Article
    15
    16
    17
    18
    19

    Correction: Sgherza et al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. Pharmaceuticals 2025, 18 , 595

    Published in:
    2025
    By:
    • Sgherza, Nicola;
    • Battisti, Olga;
    • Curci, Paola;
    • Conticello, Concetta;
    • Palmieri, Salvatore;
    • Derudas, Daniele;
    • Germano, Candida;
    • Martino, Enrica Antonia;
    • Mele, Giuseppe;
    • Della Pepa, Roberta;
    • Fazio, Francesca;
    • Mele, Anna;
    • Rossini, Bernardo;
    • Palazzo, Giulia;
    • Roccotelli, Daniela;
    • Rasola, Simona;
    • Petrucci, Maria Teresa;
    • Pastore, Domenico;
    • Tarantini, Giuseppe;
    • Pane, Fabrizio
    Publication type:
    Correction Notice
    20
    21

    Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.

    Published in:
    2021
    By:
    • Jackson, Graham H.;
    • Pawlyn, Charlotte;
    • Cairns, David A.;
    • de Tute, Ruth M.;
    • Hockaday, Anna;
    • Collett, Corinne;
    • Jones, John R.;
    • Kishore, Bhuvan;
    • Garg, Mamta;
    • Williams, Cathy D.;
    • Karunanithi, Kamaraj;
    • Lindsay, Jindriska;
    • Rocci, Alberto;
    • Snowden, John A.;
    • Jenner, Matthew W.;
    • Cook, Gordon;
    • Russell, Nigel H.;
    • Drayson, Mark T.;
    • Gregory, Walter M.;
    • Kaiser, Martin F.
    Publication type:
    journal article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 144, n. 3, p. 553, doi. 10.1007/s11060-019-03257-1
    By:
    • Correa, Denise D.;
    • Braun, Erica;
    • Kryza-Lacombe, Maria;
    • Ho, Ka-Wai;
    • Reiner, Anne S.;
    • Panageas, Katherine S.;
    • Yahalom, Joachim;
    • Sauter, Craig S.;
    • Abrey, Lauren E.;
    • DeAngelis, Lisa M.;
    • Omuro, Antonio
    Publication type:
    Article
    40

    Promising treatment results with blood brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL).

    Published in:
    Journal of Neuro-Oncology, 2017, v. 131, n. 2, p. 293, doi. 10.1007/s11060-016-2293-8
    By:
    • Kuitunen, Hanne;
    • Tokola, Susanna;
    • Siniluoto, Topi;
    • Isokangas, Matti;
    • Sonkajärvi, Eila;
    • Alahuhta, Seppo;
    • Turpeenniemi-Hujanen, Taina;
    • Jantunen, Esa;
    • Nousiainen, Tapio;
    • Vasala, Kaija;
    • Kuittinen, Outi
    Publication type:
    Article
    41

    Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients.

    Published in:
    Journal of Neuro-Oncology, 2017, v. 131, n. 2, p. 359, doi. 10.1007/s11060-016-2307-6
    By:
    • Raleigh, David;
    • Tomlin, Bryan;
    • Buono, Benedict;
    • Roddy, Erika;
    • Sear, Katherine;
    • Byer, Lennox;
    • Felton, Erin;
    • Banerjee, Anu;
    • Torkildson, Joseph;
    • Samuel, David;
    • Horn, Biljana;
    • Braunstein, Steve;
    • Haas-Kogan, Daphne;
    • Mueller, Sabine
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50